Medtide (3880.HK) Stock Price
Medtide Price
Revenue has compounded at 19.6% per year over the past 4 years to 568.85 M CNY. Earnings per share have grown at 28.3% per year over the last 4 years. Medtide's net margin stands at 38.2%, up from 28.9% several years earlier. Analysts set a median price target of 34.07 CNY, implying 87.9% above the current price. Of 9 analysts, 0 rate the stock a buy — an overall Sell consensus.
Medtide stock price
Medtide business model & stock analysis
Frequently asked questions about Medtide
Analysts currently set an average price target of 34.07 CNY for the Medtide stock (median: 34.07 CNY), implying +87.9 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Medtide stock: 0 recommend buying, 3 holding and 6 selling. For 2026, analysts expect Medtide to generate revenue of 598.59 M CNY and earnings per share of 1.27 CNY.
Converted at the current exchange rate, the Medtide share trades at 2.40 EUR (18.13 CNY).
The expected revenue of Medtide is 598.59 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Medtide is 179.67 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medtide is currently 14.31. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medtide stock.
The price-to-sales ratio (P/S) of Medtide is currently 4.29. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medtide stock.
The Eulerpool Quality Score for Medtide is 4/10.
The ISIN of Medtide is CNE100006S86. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medtide is 3880.HK. The ticker symbol is used to trade Medtide shares on the stock exchange.
Medtide stock
Medtide Peer Group
All fundamentals and in-depth analysis of Medtide
Our stock analysis for Medtide stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtide. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.